These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 762295)

  • 1. Chemotherapy of unresectable or recurrent metastatic malignant melanomas: an update.
    Block JB; Tabbarah H; Isacoff W; Drakes TP
    J Dermatol Surg Oncol; 1979 Feb; 5(2):118-23. PubMed ID: 762295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant chemoimmunotherapy stage I/II malignant melanoma.
    Knost JA; Reynolds V; Greco FA; Oldham RK
    J Surg Oncol; 1982 Mar; 19(3):165-70. PubMed ID: 7040820
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy of malignant melanoma.
    Benjamin RS
    World J Surg; 1979 Jul; 3(3):321-8. PubMed ID: 382646
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chemotherapy of malignant melanomas].
    Gallmeier WM
    Haematol Blood Transfus; 1978; 21():293-302. PubMed ID: 367896
    [No Abstract]   [Full Text] [Related]  

  • 5. Current concepts in the management of malignant melanoma.
    Lichtenfeld JL
    Am J Med Sci; 1976; 272(2):185-95. PubMed ID: 1008080
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fotemustine in the treatment of metastatic malignant melanoma. Overall analysis of results].
    Pathol Biol (Paris); 1990 Oct; 38(8):876-80. PubMed ID: 2274396
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experience with adjuvant chemoimmunotherapy with DTIC and BCG in malignant melanoma (author's transl)].
    Pullmann H; Muth M
    Z Hautkr; 1982 Feb; 57(4):294-7. PubMed ID: 7080583
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chemotherapy of malignant melanoma].
    Karakousis CP
    Chirurg; 1986 Oct; 57(10):606-11. PubMed ID: 3792110
    [No Abstract]   [Full Text] [Related]  

  • 9. [Multiple BCG-induced ulcers after subcutaneous vaccination in the framework of immunochemotherapy in malignant melanoma].
    Korting HC; Strasser S; Konz B
    Hautarzt; 1988 Mar; 39(3):170-3. PubMed ID: 3378889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The survival of patients with malignant melanoma receiving BCG with or without chemotherapy.
    Green MD; MacKay IR; Buckley JC; Coates AS
    Aust N Z J Surg; 1979 Jun; 49(3):335-9. PubMed ID: 289374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour regression and survival of patients with disseminated malignant melanoma treated with chemotherapy and specific active immunotherapy.
    Hedley DW; McElwain TJ; Currie GA
    Eur J Cancer (1965); 1977 Oct; 13(10):1169-73. PubMed ID: 923614
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapy of melanoma.
    Luce JK
    Semin Oncol; 1975 Jun; 2(2):179-85. PubMed ID: 1234375
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined modality therapy of malignant melanoma.
    Hersh EM; Gutterman JU; McBride CM
    World J Surg; 1979 Jul; 3(3):329-43. PubMed ID: 382647
    [No Abstract]   [Full Text] [Related]  

  • 14. Mumps virus and BCG vaccine in metastatic melanoma.
    Minton JP
    Arch Surg; 1973 Apr; 106(4):503-6. PubMed ID: 4572347
    [No Abstract]   [Full Text] [Related]  

  • 15. [Combination of fotemustine-dacarbazine and interferon alpha in the treatment of metastatic malignant melanoma].
    Célérier P; Dreno B; Bureau B; Litoux P
    Ann Dermatol Venereol; 1993; 120(6-7):437-40. PubMed ID: 8279787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of chemotherapy into combined modality therapy of solid tumors. IV. Malignant melanoma.
    Comis RL; Carter SK
    Cancer Treat Rev; 1974 Dec; 1(4):285-304. PubMed ID: 4619579
    [No Abstract]   [Full Text] [Related]  

  • 17. A randomized trial of adjuvant chemotherapy and immunotherapy in Stage I and Stage II cutaneous melanoma. An interim report.
    Sterchi JM; Wells HB; Case LD; Spurr CL; White DR; Richards F; Muss HB; Jackson DV; Stuart JJ; Cooper MR
    Cancer; 1985 Feb; 55(4):707-12. PubMed ID: 3967167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chemotherapy and immunotherapy on tumor-specific immunity in melanoma.
    Mitchell MS; Mokyr MB; Davis JM
    J Clin Invest; 1977 Jun; 59(6):1017-26. PubMed ID: 863999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report.
    Nathanson L; Clark DA
    Natl Cancer Inst Monogr; 1973 Dec; 39():221-4. PubMed ID: 4595321
    [No Abstract]   [Full Text] [Related]  

  • 20. [Results in the use of immunochemotherapy in patients with cutaneous malignant melanoma].
    Calbo L; Gorgone S; Palmeri R; Salibra M; Melita P
    Chir Ital; 1983 Aug; 35(4):519-25. PubMed ID: 6680859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.